• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Costs along the TB diagnostic pathway in Uganda.

作者信息

Tucker A, Oyuku D, Nalugwa T, Nantale M, Ferguson O, Farr K, Reza T F, Shete P B, Cattamanchi A, Dowdy D W, Sohn H, Katamba A

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Uganda Tuberculosis Implementation Research Consortium (U-TIRC), Kampala, Uganda.

出版信息

Int J Tuberc Lung Dis. 2021 Jan 1;25(1):61-63. doi: 10.5588/ijtld.20.0532.

DOI:10.5588/ijtld.20.0532
PMID:33384046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7927348/
Abstract
摘要

相似文献

1
Costs along the TB diagnostic pathway in Uganda.乌干达结核病诊断流程中的成本。
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):61-63. doi: 10.5588/ijtld.20.0532.
2
Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda.乌干达坎帕拉结核病诊所中新冠病毒感染的患病率。
Int J Tuberc Lung Dis. 2023 Jun 1;27(6):481-483. doi: 10.5588/ijtld.23.0010.
3
A yield and cost comparison of tuberculosis contact investigation and intensified case finding in Uganda.乌干达结核接触者调查和强化病例发现的产量和成本比较。
PLoS One. 2020 Jun 8;15(6):e0234418. doi: 10.1371/journal.pone.0234418. eCollection 2020.
4
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.乌干达坎帕拉的结核病患者的结核病风险因素：对结核病控制的影响。
BMC Public Health. 2015 Jan 21;15:13. doi: 10.1186/s12889-015-1376-3.
5
Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.乌干达坎帕拉初级保健诊所儿童结核病诊断中的护理质量。
Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1196-1202. doi: 10.5588/ijtld.18.0043.
6
Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study.2009 - 2010年乌干达坎帕拉地区儿童结核病流行病学；一项回顾性横断面研究。
BMC Public Health. 2015 Sep 25;15:967. doi: 10.1186/s12889-015-2312-2.
7
Missed opportunities in tuberculosis investigation and associated factors at public health facilities in Uganda.乌干达公共卫生机构结核病调查中的错失机会及相关因素
BMC Health Serv Res. 2021 Apr 17;21(1):359. doi: 10.1186/s12913-021-06368-6.
8
Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa.非洲城市地区结核病病例发现中社区主动病例发现和家庭接触者调查的成本效益分析
PLoS One. 2015 Feb 6;10(2):e0117009. doi: 10.1371/journal.pone.0117009. eCollection 2015.
9
Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda.第三次连续痰涂片检查在摩尔多瓦和乌干达结核病诊断中的效率
Int J Tuberc Lung Dis. 2007 Jun;11(6):659-64.
10
Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda.通过新型诊断设备放置模型优化结核病病例检测：乌干达的案例
PLoS One. 2015 Apr 1;10(4):e0122574. doi: 10.1371/journal.pone.0122574. eCollection 2015.

引用本文的文献

1
Cost-effectiveness of integrating paediatric tuberculosis services into child healthcare services in Africa: a modelling analysis of a cluster-randomised trial.将儿科结核病服务纳入非洲儿童医疗服务的成本效益：一项整群随机试验的建模分析
BMJ Glob Health. 2024 Dec 18;9(12):e016416. doi: 10.1136/bmjgh-2024-016416.
2
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.确定中复杂度分枝杆菌核酸扩增试验（NAATs）用于结核病药物敏感性检测的成本和定位决策。
PLoS One. 2023 Aug 24;18(8):e0290496. doi: 10.1371/journal.pone.0290496. eCollection 2023.
3
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis.

本文引用的文献

1
Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB).研究方案：一项评价乌干达社区卫生中心现场 GeneXpert 检测（XPEL-TB）有效性和实施情况的整群随机试验。
Implement Sci. 2020 Apr 21;15(1):24. doi: 10.1186/s13012-020-00988-y.
2
Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study.多地点医疗成本研究中使用的估算器：系统评价和模拟研究。
Value Health. 2019 Oct;22(10):1146-1153. doi: 10.1016/j.jval.2019.05.007. Epub 2019 Jul 30.
3
乌干达结核病的多组分策略与去中心化分子检测：成本和成本效益分析。
Lancet Glob Health. 2023 Feb;11(2):e278-e286. doi: 10.1016/S2214-109X(22)00509-5.
Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model.
为实现印度全民享有高质量结核病诊断而进行决策：一项经济-流行病学模型。
BMC Med. 2019 Aug 6;17(1):155. doi: 10.1186/s12916-019-1384-8.
4
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.南非基层医疗机构中即时检测 Xpert MTB/RIF 与痰涂片显微镜检查对结核病诊断的效果比较：一项多中心经济学评价。
Lancet Glob Health. 2019 Jun;7(6):e798-e807. doi: 10.1016/S2214-109X(19)30164-0.
5
Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis.赞比亚抗逆转录病毒治疗诊所的运营特征：一项时间与动作分析
BMC Health Serv Res. 2019 Apr 24;19(1):244. doi: 10.1186/s12913-019-4096-z.
6
How to implement new diagnostic products in low-resource settings: an end-to-end framework.如何在资源匮乏地区推广新型诊断产品：一个端到端的框架
BMJ Glob Health. 2018 Nov 16;3(6):e000914. doi: 10.1136/bmjgh-2018-000914. eCollection 2018.
7
Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert MTB/RIF for People Living with HIV/AIDS and People with Presumptive Multidrug-resistant Tuberculosis.柬埔寨艾滋病毒/艾滋病患者和疑似耐多药结核病患者中使用和不使用 Xpert MTB/RIF 的结核病诊断成本分析。
Appl Health Econ Health Policy. 2018 Aug;16(4):537-548. doi: 10.1007/s40258-018-0397-3.
8
Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform.应对诊断供需挑战：来自一个在线全球健康讨论平台的见解
BMJ Glob Health. 2016 Dec 2;1(4):e000132. doi: 10.1136/bmjgh-2016-000132. eCollection 2016.
9
Higher cost of implementing Xpert(®) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness.在乌干达基层医疗机构实施Xpert（®）MTB/RIF检测成本更高：对成本效益的影响
Int J Tuberc Lung Dis. 2016 Sep;20(9):1212-8. doi: 10.5588/ijtld.16.0200.
10
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?用于结核病的Xpert MTB/RIF检测的开发、推广及影响：我们学到了哪些经验教训，如何才能做得更好？
Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13.